Lexene Pharma Private Limited
Pharmaceutical company specializing in manufacturing, trading, and wholesaling of various medications.
2020 | Mahesana, Gujarat (India) | Active
Lexene Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.35 Cr
- Revenue Growth 125224.46%
- Profit Growth -341.62%
- Ebitda 57.68%
- Net Worth -69.30%
- Total Assets 32.59%
About Lexene Pharma
Lexene Pharma Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 June 2020 (Four years and nine months 10 days old ). Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹3.35 Cr.
Kinchit Patel, Mukeshkumar Patel, Mahendrakumar Patel, and Three other members serve as directors at the Company.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24119GJ2020PTC113847
- Company No.
113847
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Lexene Pharma Private Limited
Explore comprehensive data for Lexene Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Lexene Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kinchit Patel  | Director | 08-Jun-2020 | Current |
| Mukeshkumar Patel | Director | 08-Jun-2020 | Current |
| Mahendrakumar Patel | Director | 08-Jun-2020 | Current |
| Hiteshbhai Patel | Director | 09-Jul-2020 | Current |
| Ramaben Patel | Director | 09-Jul-2020 | Current |
| Jaiprabha Joshi | Director | 04-Jan-2021 | Current |
Financial Performance of Lexene Pharma.
Lexene Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 125224.46% increase. The company also saw a substantial fall in profitability, with a 341.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 69.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lexene Pharma?
Unlock access to Lexene Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹3.35 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 3.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2023 | The South Indian Bank Limited | ₹5.00 M | Open |
| 09 Aug 2021 | The South Indian Bank Limited | ₹2.85 Cr | Open |
How Many Employees Work at Lexene Pharma?
Unlock and access historical data on people associated with Lexene Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lexene Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lexene Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Lexene Pharma
Recent activity within the organization
- Annual General Meeting
Lexene Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Charges
A charge with The South Indian Bank Limited amounted to Rs. 0.50 Cr with Charge ID 100752655 was registered on 04 Jul 2023.
- Balance Sheet
Lexene Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
- Charges
A charge with The South Indian Bank Limited amounted to Rs. 2.85 Cr with Charge ID 100473925 was registered on 09 Aug 2021.
- Director Appointment
Hiteshbhai Kalidas Patel was appointed as a Director was appointed as a Director on 09 Jul 2020 & has been associated with this company since 4 years 8 months .
- Director Appointment
Ramaben Hiteshbhai Patel was appointed as a Director was appointed as a Director on 09 Jul 2020 & has been associated with this company since 4 years 8 months .
Frequently asked questions
What is the Incorporation or founding date of Lexene Pharma Private Limited?
Lexene Pharma Private Limited was incorporated on 08 Jun 2020.
What is authorized share capital and paid-up capital of Lexene Pharma Private Limited?
The authorized share capital of Lexene Pharma Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.50 Cr.
Who are the current board members & directors of Lexene Pharma Private Limited?
Currently 6 directors are associated with Lexene Pharma Private Limited.
- Kinchit Hiteshbhai Patel
- Mukeshkumar Bhogilal Patel
- Mahendrakumar Dhanabhai Patel
- Hiteshbhai Kalidas Patel
- Ramaben Hiteshbhai Patel
- Jaiprabha Joshi
What is the registered address of Lexene Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Lexene Pharma Private Limited is Plot No.497 B/H Oil Mill At Kanoda Talaka- Bechraji, Modhera Road India, Mehsana, Gujarat, 384001.
What is the corporate identification number (CIN) and company number of Lexene Pharma Private Limited?
The corporate identification number (CIN) of Lexene Pharma Private Limited is U24119GJ2020PTC113847 and the company number is 113847 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Lexene Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Lexene Pharma Private Limited has risen by 125224.46%.
What change has been observed in the net worth of Lexene Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Lexene Pharma Private Limited has experienced an downturn of -69.30%.
What are the total open charges for Lexene Pharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Lexene Pharma Private Limited amount to ₹ 3.35 Cr.
When was the last Balance Sheet of Lexene Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Lexene Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records